Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Teicoplanin in perspective. A critical comparison with vancomycin.

R Janknegt1

  • 1Department of Clinical Pharmacy, Maasland Hospital, Sittard, The Netherlands.

Pharmaceutisch Weekblad. Scientific Edition
|August 23, 1991
PubMed
Summary

Teicoplanin offers potential advantages over vancomycin, including fewer side effects and less toxicity. However, more research is needed to confirm its efficacy and address concerns about teicoplanin resistance.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The nocebo effect challenges the non-medical infliximab switch in practice.

European journal of clinical pharmacology·2018
Same author

The use of an electronic clinical rule to discontinue chronically used benzodiazepines and related Z drugs.

European journal of clinical pharmacology·2017
Same author

Usually Available Clinical and Laboratory Data Are Insufficient for a Valid Medication Review: A Crossover Study.

The journal of nutrition, health & aging·2016
Same author

SWAB/NVALT (Dutch Working Party on Antibiotic Policy and Dutch Association of Chest Physicians) guidelines on the management of community-acquired pneumonia in adults.

The Netherlands journal of medicine·2012
Same author

[Optimisation of the antibiotic policy in the Netherlands. X. The SWAB guideline for antimicrobial treatment of complicated urinary tract infections].

Nederlands tijdschrift voor geneeskunde·2006
Same author

[Optimizing the antibiotics policy in The Netherlands. VIII. Revised SWAB guidelines for antimicrobial therapy in adults with community-acquired pneumonia].

Nederlands tijdschrift voor geneeskunde·2005

Area of Science:

  • Pharmacology
  • Infectious Diseases
  • Microbiology

Background:

  • Teicoplanin is a glycopeptide antibiotic structurally similar to vancomycin.
  • Vancomycin is a widely used antibiotic for serious Gram-positive infections.

Purpose of the Study:

  • To compare the proposed advantages of teicoplanin over vancomycin.
  • To evaluate the need for further studies on clinical efficacy and resistance patterns.

Main Methods:

  • Literature review and analysis of existing studies comparing teicoplanin and vancomycin.
  • Discussion of pharmacological properties, side-effect profiles, and resistance development.

Main Results:

  • Teicoplanin may offer benefits such as reduced side effects, lower toxicity (especially with aminoglycosides), less frequent dosing, and intramuscular administration.

Related Experiment Videos

  • Limited comparative studies exist, necessitating more research.
  • Therapeutic drug monitoring is generally not required for teicoplanin, unlike vancomycin.
  • Uncertainty remains regarding the incidence of teicoplanin resistance compared to vancomycin.

    • Conclusions:

    • Teicoplanin presents a promising alternative to vancomycin.
    • Further data are required to establish definitive conclusions on relative clinical efficacy and the emergence of resistance to both antibiotics.